NDEVs isolated from the blood of AD patients have been shown to contain significantly higher levels of Aβ1–42 and p‐Tau, as well as alterations in lysosomal proteins, compared to those from healthy individuals (Goetzl et al. 2015; Abner et al. 2016) (Figure 1). The gene discussed is MAPT; the disease is Alzheimer disease.